Icon	Function
💬	A pop-up explanation appears when you mouse-over the text beside this icon. Also, an explanation window appears when you click this icon.
	The links beside this icon are links to external sites.
	Clicking this icon sorts the table by the item with this icon (Numerical or alphabetical order). Each click toggles between ascending and descending order.
	A text longer than 100 characters is fully displayed or collapsed.
	The contents of the displayed table are downloaded as a file named "table.csv".

DR info

Clinical trials : 5 / Drugs : 7 - (DrugBank : 1) / Drug target genes : 14 - Drug target pathways : 24

Drugs, Primary sponsors and Trial info (Enrollment year, Phase, Trial ID, Countries)

Concerta
   University of Geneva, Switzerland
      2016   -   NCT04647500   Switzerland
Emea/H/C/000109
   Academisch ziekenhuis Maastricht
      2021   Phase 3   EUCTR2021-002011-61-NL   Netherlands
NFC-1
   Aevi Genomic Medicine, LLC, a Cerecor company
      2016   Phase 1   NCT02895906   United States
Rilutek
   Academisch ziekenhuis Maastricht
      2021   Phase 3   EUCTR2021-002011-61-NL   Netherlands
Riluzole
   Academisch ziekenhuis Maastricht
      2021   Phase 3   EUCTR2021-002011-61-NL   Netherlands
Risperdal
   University of Geneva, Switzerland
      2017   -   NCT04639960   Switzerland
ZYN002
   Zynerba Pharmaceuticals, Inc.
      2020   Phase 1/Phase 2   NCT05149898   Australia;United States